Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.

No trades
See on Supercharts

Price target

13.250.000.00%
The 4 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to ATRA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ATRA EPS for the last quarter is −1.19 USD despite the estimation of −2.86 USD. In the next quarter EPS is expected to reach −2.25 USD. Track more of Atara Biotherapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Atara Biotherapeutics, Inc. revenue is expected to reach ‪10.12 M‬ USD. Check out Atara Biotherapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ATRA price target is 13.25 USD with a max estimate of 18.00 USD and a min estimate of 7.00 USD. Check if this forecast comes true in a year, meanwhile watch Atara Biotherapeutics, Inc. stock price chart and keep track of the current situation with ATRA news and stock market news.
We've gathered opinions of 6 analysts rating ATRA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.